← Back to Analyst Consensus 
AGIO Buy
AGIOS PHARMACEUTICALS, INC.
Current Price —
Implied Upside —
Analysts 16
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 7, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Sep 21, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Aug 7, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| Jul 31, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Jul 31, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jul 30, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 21, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 7, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | — | 55% |
| Jul 7, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jul 7, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Jun 15, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jun 11, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| May 29, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Apr 30, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Apr 21, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Apr 20, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Apr 6, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| Apr 1, 2026 | Goldman Sachs | maintain | Neutral → Neutral | — | 54% |
| Mar 5, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Feb 12, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $65 | 44% |
| Jan 6, 2026 | JP Morgan | maintain | Neutral → Neutral | $25 | 55% |
| Dec 26, 2025 | Leerink Partners | maintain | Outperform → Outperform | $40 | 50% |
| Dec 24, 2025 | Truist Securities | maintain | Buy → Buy | $38 | 54% |
| Dec 24, 2025 | B of A Securities | maintain | Buy → Buy | $34 | 53% |
| Dec 24, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $62 | 44% |
| Nov 26, 2025 | Citigroup | initiate | — → Buy | $38 | 54% |
| Nov 24, 2025 | Truist Securities | initiate | — → Buy | $32 | 54% |
| Nov 21, 2025 | JP Morgan | maintain | Neutral → Neutral | $20 | 55% |
| Nov 20, 2025 | RBC Capital | downgrade | Outperform → Sector Perform | $28 | 55% |
| Nov 20, 2025 | B of A Securities | maintain | Buy → Buy | $32 | 53% |
| Nov 20, 2025 | Leerink Partners | upgrade | Market Perform → Outperform | $34 | 50% |
| Nov 20, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $25 | 54% |
| Nov 20, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $48 | 44% |
| Sep 4, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $56 | 44% |
| Jul 28, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $65 | 55% |
| Jul 22, 2025 | B of A Securities | maintain | Buy → Buy | $51 | 53% |
| May 2, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $71 | 55% |
| Feb 24, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $58 | 44% |
| Dec 18, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $0 | 50% |
| Dec 10, 2024 | RBC Capital | maintain | Outperform → Outperform | $57 | 55% |
| Dec 9, 2024 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $75 | 55% |
| Nov 1, 2024 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $53 | 55% |
| Oct 16, 2024 | Scotiabank | initiate | — → Sector Outperform | $51 | 55% |
| Sep 27, 2024 | Leerink Partners | downgrade | Outperform → Market Perform | $56 | 50% |
| Sep 20, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Sep 19, 2024 | RBC Capital | reiterate | Outperform → Outperform | $55 | 55% |
| Aug 2, 2024 | RBC Capital | maintain | Outperform → Outperform | $55 | 55% |
| Jun 17, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Jun 4, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $53 | 54% |
| Jun 4, 2024 | RBC Capital | maintain | Outperform → Outperform | $53 | 55% |
Price Target Trend
Apr 6, 2026 Oct 26, 2026
EPS Estimates
+1q —
0q —
+1y —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days